You are here

chronic kidney disease

VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study

MarketWatch

Sat, 11/20/10 - 01:35 pm

chronic kidney disease

Private Biotechs Take Different Avenues to Rake in Cash

Seeking Alpha

Sun, 09/26/10 - 12:45 pm

Abbott Laboratories

chronic kidney disease

Boston Scientific

Emergent BioSolutions

Impax Laboratories Confirms Patent Challenge Relating to RENVELA®, 2.4 g and 0.8 g (For Suspension)

Yahoo/BusinessWire

Sat, 07/3/10 - 10:06 am

chronic kidney disease

Pages